US20150079225A1 - Nutritional composition - Google Patents

Nutritional composition Download PDF

Info

Publication number
US20150079225A1
US20150079225A1 US14/391,494 US201314391494A US2015079225A1 US 20150079225 A1 US20150079225 A1 US 20150079225A1 US 201314391494 A US201314391494 A US 201314391494A US 2015079225 A1 US2015079225 A1 US 2015079225A1
Authority
US
United States
Prior art keywords
nutritional composition
content
formula
composition according
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/391,494
Other languages
English (en)
Inventor
Bo Lönnerdal
Olle Hernell
Lars-Börje Sjöberg
Catharina Tennefors
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hero AG
Original Assignee
Hero AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48289048&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20150079225(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hero AG filed Critical Hero AG
Assigned to HERO AG reassignment HERO AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SJÖBERG, Lars-Börje, TENNEFORS, CATHARINA, HERNELL, OLLE, LÖNNERDAL, Bo
Publication of US20150079225A1 publication Critical patent/US20150079225A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A23L1/296—
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/207—Co-precipitates of casein and lactalbumine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A23L1/293—
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • Phospholipids, sphingomyelin, sialic acid, gangliosides are all nutrients which are recognized as important nutrients for the infant.
  • the challenge has been to be able to incorporate suitable sources of these nutrients into the composition of the formula without negative effect on other important nutrients and the general composition of the product.
  • this incorporation has been performed in levels close to the level in breast milk without any negative effect on the total composition.
  • a nutritional composition according to the invention may also refer to the composition of the invention as a powder suitable for making a liquid composition after reconstitution with water.
  • a nutritional composition according to the present invention wherein the amino acid content in the composition is originated from sources selected from for example; sweet whey solids, casein solids, milk solids and cream solids.
  • a nutritional composition also referred to as a formula according to the invention is for example a powder intended to be mixed with water before use or a liquid ready-to-use product.
  • a nutritional composition according to the invention has low energy content in combination with low protein content.
  • a nutritional composition according to the invention is more nutritional complete and comprises several milk derived raw materials including sweet whey, whey protein concentrate rich in phospholipids, cream rich in cholesterol and also comprises gluco macro peptide (cGMP) which allows for a higher sialic acid content.
  • cGMP gluco macro peptide
  • Another important factor of the present invention is that it further may have low non-protein nitrogen content (NPN).
  • the formula according to the invention comprises a low level of protein and also a low level of total energy content.
  • the protein content of the ready to drink nutritional composition is for example lower than 1.25 g/100 ml or for example lower than 1.25 g/100 ml or for example between 1.1-1.25 g/100 ml or between 1.1 g/100 ml to lower than 1.25 g/100 ml.
  • rape seed oil contributes mainly with the essential fatty acid linolenic acid (n-3 18:3).
  • Other oils which also may be used are: rape seed oil (high oleic), soybean-, maize-, safflower-, evening primrose-, borage-, palm-, palm olein-, palm kernel-, coconut-, babassu-, fish oil, egg lipids, structured fat with high percent palmitic acid esterified to ⁇ -position in the triglycerides and lard. In order to even better mimic the fat composition in breast milk cream is used.
  • the levels of arachidonic acid (ARA) and docosahexaenoic acid (DHA) in the nutritional composition according to the invention are of similar levels as present in breast milk.
  • an infant formula needs a predetermined amino acid profile to fulfill the children's need. This is also regulated by the government Commission Directive 2006/141/EC.
  • the amino acid supply in an infant's first months of life must be sufficient in quantity as well as quality to fulfill the needs of this period of life. Guidelines, recommendations with minimum values have been established with regard to amino acid composition of infant formulas.
  • An amino acid profile of the nutritional composition according to the invention is presented in the table below. The clinical study confirms that the amino acid composition in the invention formula is adequate for the requirement for growth.
  • the formula according to the invention is according to one embodiment produced by mixing the below ingredients in kg per 1000 kg nutritional composition dry powder or kg per 8770 L finished nutritional composition.
  • the nutritional composition may further comprise vitamins, minerals, fats, lactose and/or other essential nutrients (for example choline, taurine, inositol, carnitine, nucleotides).
  • vitamins, minerals, fats, lactose and/or other essential nutrients for example choline, taurine, inositol, carnitine, nucleotides.
  • Whey protein concentrate solids rich in phospholipids used as a component in the nutritional composition according to the invention is a whey protein concentrate with a high concentration of bioactive proteins and lipids.
  • the whey protein concentrate has a high nutritional value, and is applicable in infant and clinical nutrition.
  • Whey protein concentrate solids rich in phospholipids contain most of the insoluble membrane protein fragments from MFGM originally present in the whey, in addition to residual whey components, proteins, lactose and salts.
  • the invention utilizes, whey protein concentrate solids rich in phospholipids obtained after removal of the major whey proteins by known industrial processing, such as filtration, ion-exchange chromatography, and the like.
  • Whey protein concentrate solids rich in phospholipids from bovine milk contain unique polar lipids and membrane specific proteins, for example lactoferrin, butyrophilin, MUC1 and PAS6/7 (lactadherin), CD14, TLR1, and TLR4 and phospholipids (including for example sphingomyelin and gangliosides). These components are recognized as nutritional and bioactive milk constituents and are present only scarcely in bovine milk compared to human milk.
  • Sodium caseinate or partly other salts of caseinates may be used in the invention formula.
  • the composition is a powder suitable for making a liquid composition after reconstitution with water.
  • the composition is a ready to use liquid product.
  • Formula A which is a nutritional composition according to the invention, with the ingredients described above, comprises the nutritional values presented below as ready for consumption (114 g of powder formula A is mixed with 900 ml water which gives 1000 ml ready to drink product);
  • the cholesterol level in breast milk is often said to contain about 120 mg/l, but is dependant of many factors. Most standard infant formula contains less than 10 mg/ of cholesterol.
  • the cholesterol level in the Formula A was increased by using a recipe containing milk cream, milk protein fractions containing MFGM (milk fat globule membrane) and other milk protein fractions containing cholesterol.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
US14/391,494 2012-04-10 2013-04-09 Nutritional composition Abandoned US20150079225A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1250357A SE536599C3 (sv) 2012-04-10 2012-04-10 Näringssammansättning med lågt kalori- och lågt proteininnehåll
SE1250357-9 2012-04-10
PCT/EP2013/057405 WO2013153071A2 (en) 2012-04-10 2013-04-09 A nutritional composition

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/057405 A-371-Of-International WO2013153071A2 (en) 2012-04-10 2013-04-09 A nutritional composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/244,304 Continuation US11647777B2 (en) 2012-04-10 2016-08-23 Nutritional composition

Publications (1)

Publication Number Publication Date
US20150079225A1 true US20150079225A1 (en) 2015-03-19

Family

ID=48289048

Family Applications (3)

Application Number Title Priority Date Filing Date
US14/391,494 Abandoned US20150079225A1 (en) 2012-04-10 2013-04-09 Nutritional composition
US15/244,304 Active US11647777B2 (en) 2012-04-10 2016-08-23 Nutritional composition
US18/134,775 Pending US20230248043A1 (en) 2012-04-10 2023-04-14 Nutritional composition

Family Applications After (2)

Application Number Title Priority Date Filing Date
US15/244,304 Active US11647777B2 (en) 2012-04-10 2016-08-23 Nutritional composition
US18/134,775 Pending US20230248043A1 (en) 2012-04-10 2023-04-14 Nutritional composition

Country Status (11)

Country Link
US (3) US20150079225A1 (sv)
EP (4) EP2836084B1 (sv)
CN (3) CN107518410A (sv)
DK (4) DK2836084T3 (sv)
ES (4) ES2624541T3 (sv)
FI (1) FI3942944T3 (sv)
LT (4) LT3942944T (sv)
PT (4) PT3942944T (sv)
RU (1) RU2617606C2 (sv)
SE (1) SE536599C3 (sv)
WO (1) WO2013153071A2 (sv)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160366916A1 (en) * 2015-06-18 2016-12-22 Cambrooke Therapeutics, Inc. Formula for management of phenylketonuria
WO2017102720A1 (en) * 2015-12-14 2017-06-22 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
WO2017102717A1 (en) * 2015-12-14 2017-06-22 Nestec S.A. Nutritional composition and infant formula for promoting de novo myelination
US20180213833A1 (en) * 2017-01-29 2018-08-02 Samit Gupta Ketogenic nutritional composition and preparation method thereof
US11647777B2 (en) 2012-04-10 2023-05-16 Semper Ab Nutritional composition
CN118506984A (zh) * 2024-07-17 2024-08-16 南京医科大学 一种早产儿母乳强化剂个体化管理系统

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
SE537951C2 (sv) 2013-07-01 2015-12-01 Hero Ag Profylaktisk användning av modersmjölksersättning mot otit
DK3091973T3 (en) 2013-11-01 2018-11-05 Nutricia Nv LIPID COMPOSITION FOR IMPROVING BODY COMPOSITION DURING GROWTH
RU2016116835A (ru) * 2013-11-05 2017-12-11 Хиллс Пет Нутришн, Инк. Способы и композиции для улучшения функции почек
US20170000182A1 (en) * 2013-11-29 2017-01-05 Nestec S.A. Nutritional compositions with phospholipids
MX2016007712A (es) 2013-12-12 2016-09-07 Nestec Sa Composiciones sinteticas de leche para infantes menores que tres meses de edad y para infantes y niños mayores que tres meses para asegurar el crecimiento optimo y prevenir la obesidad.
RU2717339C2 (ru) * 2013-12-13 2020-03-23 Сосьете Де Продюи Нестле С.А. Применение содержащей сладкую молочную сыворотку детской смеси для обеспечения постнатального развития нервной системы желудочно-кишечного тракта младенца и формирования функций кишечника, которыми она управляет
US20200221750A1 (en) 2015-08-27 2020-07-16 Nestec S.A. Synthetic nutritional compositions tailored for infants of specific ages, and nutritional systems comprising them
WO2017032886A1 (en) * 2015-08-27 2017-03-02 Nestec S.A. Gender specific synthetic nutritional compositions and nutritional systems comprising them
CN108135242A (zh) 2015-10-15 2018-06-08 N·V·努特里奇亚 用于促进健康生长的具有特殊脂质结构的婴儿配方物
RU2728720C2 (ru) 2015-10-15 2020-07-30 Н.В. Нютрисиа Детская смесь c молочным жиром для стимулирования здорового роста
BR112018067926A2 (pt) * 2016-03-30 2019-01-02 Nestec Sa composições nutricionais e seus usos
AU2017373837B2 (en) 2016-12-09 2022-07-14 N.V. Nutricia Nutritional composition for improving cell membranes
WO2018202636A1 (en) * 2017-05-03 2018-11-08 Nestec S.A. Whey protein extracts and their use as sphingomyelin source
RU2668400C1 (ru) * 2017-05-10 2018-09-28 федеральное государственное бюджетное образовательное учреждение высшего образования "Вологодская государственная молочнохозяйственная академия имени Н.В. Верещагина" (ФГБОУ ВО Вологодская ГМХА) Способ производства молочного концентрированного продукта с сахаром
DE102018112898A1 (de) * 2018-05-30 2019-12-05 Westfälische Wilhelms-Universität Münster Essbare Cholesterol-enthaltende Emulsionen
EP3646739A1 (en) 2018-11-01 2020-05-06 N.V. Nutricia Nutritional composition comprising urea and non-digestible oligosaccharides
TW202114543A (zh) 2019-07-12 2021-04-16 荷蘭商弗里斯蘭康必奶荷蘭有限公司 誘導飽足感之方法
US20220386674A1 (en) * 2019-11-13 2022-12-08 Societe Des Produits Nestle S.A. Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol
PL4096440T3 (pl) * 2020-01-31 2024-07-29 N.V. Nutricia Kompozycja odżywcza do stosowania w dojrzewaniu jelit
CN113892649B (zh) * 2020-06-18 2024-07-09 湖南农业大学 一种益生菌微胶囊及其制备方法
CN114208894A (zh) * 2021-11-30 2022-03-22 内蒙古伊利实业集团股份有限公司 一种含有磷脂组合物的配方奶粉及其制备方法与应用
CN114568705B (zh) * 2022-03-22 2023-04-25 中国农业大学 一种有利于锌吸收的蛋白口服液及其制备方法
WO2023203156A1 (en) 2022-04-20 2023-10-26 N.V. Nutricia Infant formula with special lipid architecture for reducing childhood blood pressure
CN115517363A (zh) * 2022-09-16 2022-12-27 国家卫生健康委科学技术研究所 一种鞘磷脂燕窝酸乳清蛋白粉及其制备方法
CN117378762A (zh) * 2023-12-12 2024-01-12 内蒙古伊利实业集团股份有限公司 一种影响海马体中纤维束丰富程度的营养组合物及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265462A1 (en) * 2003-06-24 2004-12-30 University Of Kansas Medical Center Nutritional supplement
WO2007073192A2 (en) * 2005-12-23 2007-06-28 N.V. Nutricia Infant nutritional compositions for preventing obesity
US20080003330A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
US20100068149A1 (en) * 2006-11-02 2010-03-18 N.V. Nutricia Use of nutritional compositions for preventing disorders

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1049516B (it) * 1970-07-23 1981-02-10 Erba Carlo Spa Prodotto dietetico impiegabile come correttore fisiologico del latte vaccino e procedimento per la sua fabbricazione
JP3137268B2 (ja) 1991-05-20 2001-02-19 明治乳業株式会社 高コレステロ−ル含有乳製品
US6136858A (en) * 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US20040166232A1 (en) 2002-12-23 2004-08-26 Bausch & Lomb Incorporated Surface treatment utilizing microwave radiation
US20050175759A1 (en) 2004-02-09 2005-08-11 Atul Singhal Newborn infant formulas and feeding methods
US7867541B2 (en) 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
US7951410B2 (en) 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
CN101087539A (zh) 2004-12-27 2007-12-12 雀巢技术公司 蛋白质含量降低的婴儿配方的用途
PT1800675E (pt) * 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
MY148280A (en) 2006-03-23 2013-03-29 Nutricia Nv Preterm formula
US7762160B2 (en) 2006-06-26 2010-07-27 Mccoy Corporation Power tong cage plate lock system
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
TW200824582A (en) * 2006-08-29 2008-06-16 Martek Biosciences Corp Use of DPA(n-6) oils in infant formula
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
WO2008081934A1 (ja) * 2006-12-28 2008-07-10 Meiji Dairies Corporation 乳由来リン脂質を含有する乳幼児脳発達促進剤及びそれを含有する食品組成物
MY157300A (en) 2007-10-19 2016-05-31 Fontera Co Operative Group Ltd Methods of maintaining or increasing growth or cognitive development
RU2488283C2 (ru) * 2007-11-01 2013-07-27 Энзимотек Лтд. Липидная смесь для детского питания
WO2009082214A1 (en) * 2007-12-21 2009-07-02 N.V. Nutricia Use of non-digestible carbohydrates for improving intestinal microbiota
FR2930406B1 (fr) 2008-04-29 2011-04-15 Groupe Lactalis Aliment infantile a base de matiere grasse d'origine laitiere
EA011075B1 (ru) * 2008-06-20 2008-12-30 Лев Михайлович МОГИЛЕВСКИЙ Сухая молочная смесь
SI2554056T1 (sl) 2008-09-02 2020-02-28 N.V. Nutricia Prehranski sestavki z lipidnimi globulami velikega premera z oblogo, ki obsega fosfolipide
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
WO2010068086A1 (en) * 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
EP2258218A1 (en) 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
CN103153095B (zh) * 2010-08-24 2015-07-22 雅培制药有限公司 具有改良感官特性的营养产品
EP2465359A1 (en) * 2010-12-15 2012-06-20 Nestec S.A. Improved nutritional composition, especially for infants, with particular fat particles
WO2012173467A1 (en) 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
WO2013036102A1 (en) 2011-09-08 2013-03-14 N.V. Nutricia Use of infant formula with cholesterol
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
WO2014058301A1 (en) 2012-10-12 2014-04-17 N.V. Nutricia Infant nutrition with lipid globules to increase energy expenditure and metabolic flexibility later in life

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265462A1 (en) * 2003-06-24 2004-12-30 University Of Kansas Medical Center Nutritional supplement
WO2007073192A2 (en) * 2005-12-23 2007-06-28 N.V. Nutricia Infant nutritional compositions for preventing obesity
US20080003330A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
US20100068149A1 (en) * 2006-11-02 2010-03-18 N.V. Nutricia Use of nutritional compositions for preventing disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ruth A. Lawrence, Robert Michael Lawrence, Breastfeeding: A Guide for the Medical Profession, Elsevier Health Sciences, 2011, 120-121. *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11647777B2 (en) 2012-04-10 2023-05-16 Semper Ab Nutritional composition
US20160366916A1 (en) * 2015-06-18 2016-12-22 Cambrooke Therapeutics, Inc. Formula for management of phenylketonuria
EP4233875A3 (en) * 2015-12-14 2023-09-06 Société des Produits Nestlé S.A. Nutritional composition an infant formula for prmoting de novo myelination
CN108495561A (zh) * 2015-12-14 2018-09-04 雀巢产品技术援助有限公司 用于促进重新髓鞘形成的营养组合物和婴儿配方食品
RU2766598C2 (ru) * 2015-12-14 2022-03-15 Сосьете Де Продюи Нестле С.А. Питательная композиция и детская смесь для стимулирования первичной миелинизации
US11297872B2 (en) 2015-12-14 2022-04-12 Societe Des Produits Nestle S.A. Nutritional composition and infant formula for promoting de novo myelination
WO2017102717A1 (en) * 2015-12-14 2017-06-22 Nestec S.A. Nutritional composition and infant formula for promoting de novo myelination
WO2017102720A1 (en) * 2015-12-14 2017-06-22 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
EP4233906A3 (en) * 2015-12-14 2023-09-06 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas to promote myelination in the brain
US11986003B2 (en) 2015-12-14 2024-05-21 Societe Des Produits Nestle S.A. Nutritional composition and infant formula for promoting de novo myelination
US20180213833A1 (en) * 2017-01-29 2018-08-02 Samit Gupta Ketogenic nutritional composition and preparation method thereof
US10842178B2 (en) * 2017-01-29 2020-11-24 Samit Gupta Ketogenic nutritional composition and preparation method thereof
CN118506984A (zh) * 2024-07-17 2024-08-16 南京医科大学 一种早产儿母乳强化剂个体化管理系统

Also Published As

Publication number Publication date
CN107259527A (zh) 2017-10-20
LT2836084T (lt) 2017-03-27
WO2013153071A3 (en) 2013-11-28
PT3942944T (pt) 2023-08-18
CN104411184A (zh) 2015-03-11
CN104411184B (zh) 2017-09-12
LT3590358T (lt) 2021-11-10
EP2836084B1 (en) 2016-12-21
ES2894886T3 (es) 2022-02-16
EP3942944A1 (en) 2022-01-26
FI3942944T3 (sv) 2023-08-30
EP3590358A1 (en) 2020-01-08
SE536599C3 (sv) 2017-01-10
LT3175719T (lt) 2019-11-25
DK3942944T3 (da) 2023-08-21
EP3590358B1 (en) 2021-08-11
ES2952286T3 (es) 2023-10-30
RU2617606C2 (ru) 2017-04-25
WO2013153071A2 (en) 2013-10-17
RU2014139123A (ru) 2016-05-27
PT3175719T (pt) 2019-11-25
DK3175719T3 (da) 2019-11-11
EP2836084A2 (en) 2015-02-18
ES2757404T3 (es) 2020-04-29
CN107259527B (zh) 2020-12-11
PT3590358T (pt) 2021-10-21
SE1250357A1 (sv) 2013-10-11
DK2836084T3 (en) 2017-03-20
US11647777B2 (en) 2023-05-16
EP3942944B1 (en) 2023-06-07
EP3175719A1 (en) 2017-06-07
EP3175719B1 (en) 2019-09-04
DK3590358T3 (da) 2021-10-18
LT3942944T (lt) 2023-09-11
US20230248043A1 (en) 2023-08-10
US20170013869A1 (en) 2017-01-19
ES2624541T3 (es) 2017-07-14
CN107518410A (zh) 2017-12-29
SE536599C2 (sv) 2014-03-18
PT2836084T (pt) 2017-03-16

Similar Documents

Publication Publication Date Title
US20230248043A1 (en) Nutritional composition
KR100955408B1 (ko) 증가된 양의 알파-락트알부민을 포함하는 유아용 조제유
US9889162B2 (en) Prophylactic use for prevention of infections
CA2902566C (en) Method of enhancing bioavailability of dha and other lipid-soluble nutrients
Guo Biochemistry of human milk
WO2021094241A1 (en) USE OF α-LACTALBUMIN ENRICHED WHEY PROTEIN EXTRACT AS A SOURCE OF CHOLESTEROL

Legal Events

Date Code Title Description
AS Assignment

Owner name: HERO AG, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LOENNERDAL, BO;HERNELL, OLLE;SJOEBERG, LARS-BOERJE;AND OTHERS;SIGNING DATES FROM 20150108 TO 20150113;REEL/FRAME:034852/0428

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION